Real-time enrollment status for this relapsed or refractory large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 3:47 AM UTC
| NCT Number | NCT06788964 |
| Recruiting Status | Recruiting |
| Condition | Relapsed or Refractory Large B-cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 29 participants |
| Active Locations | 2 sites in the US |
| Sponsor | University of Utah |
| Last Updated on CT.gov | September 25, 2026 (2 weeks ago) |
As of October 15, 2026: Clinical trial NCT06788964 is currently recruiting participants. This phase2 study for relapsed or refractory large b-cell lymphoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by University of Utah. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06788964 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06788964 was last updated 2 weeks ago (September 25, 2026). HelloStudys verifies this status automatically.